Aquatic High-Intensity Interval Training Aids Exercise Capacity for Chronic Conditions
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Nov. 22, 2023 -- Aquatic high-intensity interval training (AHIIT) improves exercise capacity in people with a range of chronic conditions, according to a review published online Nov. 14 in BMJ Open Sport & Exercise Medicine.
Heidi Bunæs-Næss, from Oslo Metropolitan University in Norway, and colleagues conducted a systematic literature review to investigate the effect of AHIIT on exercise capacity in people with chronic conditions (musculoskeletal, respiratory, cardiovascular, metabolic, or neurological).
Based on 18 included studies (868 participants), the researchers found moderate certainty in evidence according to the Grading of Recommendations Assessment, Development and Evaluation system for a moderate beneficial effect of AHIIT on exercise capacity (standardized mean differences [SMD], 0.78; 95 percent confidence interval [CI], 0.48 to 1.08; P < 0.00001) versus a nonexercising control group. Compared with land-based HIIT, there was moderate certainty in evidence for no difference of effects on exercise capacity (SMD, 0.28; 95 percent CI, −0.04 to 0.60; P = 0.08) with AHIIT. Compared with aquatic moderate-intensity continuous training, AHIIT had moderate certainty in evidence for a small effect on exercise capacity (SMD, 0.45; 95 percent CI, 0.10 to 0.80; P = 0.01).
"Aquatic HIIT may increase adherence to exercise training and should be considered as an exercise option," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-11-23 00:52
Read more
- Want to Slowly Cut Down on Dietary Salt? Here's How
- Exposure to Inorganic Arsenic in Drinking Water Increases Cardiovascular Risk
- Election Stressing You Out? An Expert Has Coping Tips
- American Thoracic Society Provides Tips for Hospitals to Manage IV Fluid Supply Amid Shortage
- Gene Therapy Might Tweak Fats, Help Prevent Arthritis in Overweight Kids
- Cognitive Therapy, Modafinil, Combo All Beneficial for Multiple Sclerosis Fatigue
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions